Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

The new tool injects real-time budget awareness into agent reasoning loops, tackling runaway compute and tool calls.

The internet videos are alarming to some, thrilling to others: Gun enthusiasts spraying bullets from AR-15-style rifles equipped with an after-market trigger allowing them to shoot seemingly as fast ...

After one of the driest Decembers in decades, Northern and Central California began to see rain again on Tuesday as a strengthening series of storms was set to soak the region, forecasters said. The ...